US2021177910A1PendingUtilityA1

Method for inducing angiogenesis

Assignee: MIMEDX GROUP INCPriority: Jan 17, 2014Filed: Oct 13, 2020Published: Jun 17, 2021
Est. expiryJan 17, 2034(~7.5 yrs left)· nominal 20-yr term from priority
Inventors:Thomas J. Koob
A61P 43/00A61P 11/00A61L 2300/414A61P 9/10A61L 27/3804A61K 35/50A61L 27/3604A61P 1/16A61P 19/00A61L 27/54A61P 3/10A61L 2400/06A61P 17/02A61P 25/02A61K 9/0014A61K 35/28
66
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed herewith is a method for inducing angiogenesis using modified placental tissue or an extract thereof to treat conditions other than cardiovascular conditions.

Claims

exact text as granted — not AI-modified
1 .- 16 . (canceled) 
     
     
         17 . A method for inducing angiogenesis in a non-cardiovascular body region of a subject in need thereof comprising delivering an effective amount of a composition comprising placental growth factors and/or stem cells extracted from placental tissue to said non-cardiovascular body region. 
     
     
         18 .- 26 . (canceled) 
     
     
         27 . The method of  claim 17 , wherein the placental growth factors and/or stem cells are extracted from one or more of isolated amnion, isolated chorion, intermediate tissue, Wharton's jelly, isolated amniotic epithelial layer, or any combination thereof. 
     
     
         28 . The method of  claim 17 , wherein the composition is injectable. 
     
     
         29 . The method of  claim 17 , wherein the composition is a liquid, gel, or paste. 
     
     
         30 . The method of  claim 17 , wherein the composition is employed by a nebulizer. 
     
     
         31 .- 32 . (canceled) 
     
     
         33 . The method of  claim 17 , wherein blood flow to the non-cardiovascular body region is restricted. 
     
     
         34 . The method of  claim 33 , wherein the blood flow to the non-cardiovascular body region is restricted due to injury or disease. 
     
     
         35 . The method of  claim 17 , wherein the non-cardiovascular body region comprises a peripheral portion of the body, liver, lung, nerve, bone, or skin. 
     
     
         36 . The method of  claim 35 , wherein the peripheral portion of the body is selected from the group consisting of limbs, hands, and feet. 
     
     
         37 . The method of  claim 17 , wherein the subject has or is at risk of developing peripheral neuropathy, cirrhosis, a pulmonary condition, or other non-cardiovascular condition. 
     
     
         38 . The method of  claim 37 , wherein the pulmonary condition is selected from the group consisting of cystic fibrosis, pulmonary fibrosis, and chronic obstructive pulmonary disease (COPD). 
     
     
         39 . The method of  claim 37 , wherein the other non-cardiovascular conditions comprise bone necrosis, ischemia, organ injury, tissue injury, or a chronic wound. 
     
     
         40 . The method of  claim 39 , wherein the ischemia is limb ischemia. 
     
     
         41 . The method of  claim 39 , wherein the chronic wounds are associated with systemic disease. 
     
     
         42 . The method of  claim 41 , wherein the systemic disease is selected from the group consisting of diabase and non-cardiovascular atherosclerosis.

Join the waitlist — get patent alerts

Track US2021177910A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.